McGrail et al. suggested that the count of CD8+ T cells in lung cancer is positively correlated with neoantigen load, with a significantly higher objective response rate in tumors with high tumor mutation burden (TMB) compared to those with low TMB [15]. The gene discussed is CD8A; the disease is neoplasm.